Who invested in Immusoft?
7 investors are on record as having backed Immusoft — Engineering patient immune cells to produce therapies, in Biotech, United States. Each row below says whether the round came from the investor's own portfolio page or from the press.
immusoft.comImmusoft investors
DEFTA PartnersBacks healthcare and ICT technologies, including advanced therapeutics, health ICT, and…series-b$20MJan 2019press
Biovision VenturesBacks early-stage life sciences and healthcare companies translating science into…their site
5 more investors on record for Immusoft.
The first two are open to everyone. A free account opens the rest — the fund, the round, the amount and where each number came from. No card, no demo call.
The funds that backed Immusoft are in the directory.
If they wrote this cheque, they may write yours. Pitch2Fund scores your startup against every one of them, gives you the partner to write to, and drafts the email. Free.